GlassScriptPhysician profile
Nicholas Caprio
NPI 1477137792
$11,866.44
in general payments reported to CMS, 2019-2025
73 companies · $3,288 in 2025
The $3,288 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $826 · 2022: $1,968 · 2023: $2,763 · 2024: $3,021 · 2025: $3,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,740 · Education: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,739.51 |
| Education | $333.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,550.77 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Celgene Corporation | $835.45 | 2021-2025 | Reblozyl, Pomalyst, Opdivo |
| Astrazeneca Pharmaceuticals LP | $781.29 | 2021-2025 | Enhertu, Tagrisso, Calquence |
| Daiichi Sankyo INC. | $730.57 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Merck Sharp & Dohme LLC | $638.25 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $543.36 | 2021-2025 | |
| Pfizer INC. | $508.36 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $453.78 | 2021-2025 | |
| Seagen INC. | $406.99 | 2021-2025 | Tukysa |
| Amgen INC. | $354.50 | 2021-2023 | Kyprolis, Riabni, Nplate |
| Glaxosmithkline, LLC. | $323.77 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| Astellas Pharma US INC | $262.85 | 2022-2025 | Xtandi, Padcev, Vyloy |
| Lilly USA, LLC | $243.58 | 2021-2025 | Verzenio, Jaypirca |
| Jazz Pharmaceuticals INC. | $226.09 | 2021-2025 | |
| Incyte Corporation | $224.50 | 2022-2025 | Monjuvi, Jakafi, Zynyz |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $223.22 | 2022-2025 | Opdivo, Opdualag |
| Abbvie INC. | $205.31 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $195.74 | 2023-2025 | Iclusig, Alunbrig, Fruzaqla |
| Genzyme Corporation | $188.91 | 2021-2025 | |
| Stemline Therapeutics INC. | $180.04 | 2023-2025 | Orserdu |
| Puma Biotechnology, INC. | $161.65 | 2021-2025 | |
| Genentech USA, INC. | $158.25 | 2022-2025 | Venclexta, Itovebi, Polivy |
| Exelixis INC. | $151.93 | 2023-2025 | Cabometyx |
| Sobi, INC | $139.54 | 2022-2025 | |
| Array Biopharma INC | $136.84 | 2022-2025 | Lorbrena, Braftovi, Mektovi |
| Mirati Therapeutics, INC. | $114.76 | 2023 | Krazati |
| Kyowa Kirin, INC. | $108.02 | 2023-2024 | Poteligeo |
| Pharmacyclics LLC, An Abbvie Company | $96.05 | 2023 | Imbruvica, Epkinly |
| Ipsen Biopharmaceuticals, INC | $95.39 | 2021-2025 | Onivyde, Somatuline Depot, Tazverik |
| Pharmacosmos Therapeutics INC. | $88.48 | 2022-2024 | Monoferric |
| Tersera Therapeutics LLC | $84.54 | 2023-2025 | Zoladex, Quzyttir |
| Eisai INC. | $69.14 | 2024-2025 | |
| Foundation Medicine, INC. | $69.05 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $67.94 | 2023-2025 | Libtayo |
| Aveo Pharmaceuticals, INC. | $65.86 | 2022-2024 | |
| Servier Pharmaceuticals LLC | $63.31 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $58.36 | 2025 | Alymsys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.00 | 2025 | |
| G1 Therapeutics, INC. | $51.07 | 2022-2023 | Cosela |
| Pharmaessentia USA Corporation | $49.28 | 2023-2025 | Besremi |
| Geron Corporation | $49.12 | 2025 | Rytelo |
| Accord Healthcare, INC. | $42.65 | 2023 | |
| Recordati_rare_diseases_inc. | $39.29 | 2024-2025 | Enjaymo, Sylvant |
| Sun Pharmaceutical Industries INC. | $39.15 | 2025 | |
| Coherus Oncology, INC. | $38.42 | 2023-2024 | |
| Agios Pharmaceuticals, INC. | $36.56 | 2024-2025 | Pyrukynd |
| Myriad Genetic Laboratories, INC. | $33.34 | 2021-2023 | Precisetumor |
| Karyopharm Therapeutics INC. | $32.81 | 2021-2022 | |
| Taiho Oncology, INC. | $30.79 | 2022-2023 | |
| Tolmar, INC. | $30.73 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $30.73 | 2025 | Rubraca |
| Heron Therapeutics, INC. | $29.77 | 2022 | |
| Azurity Pharmaceuticals, INC. | $26.24 | 2025 | Danziten |
| Caris Mpi, INC. | $25.74 | 2025 | Mi Cancer Seek |
| Dova Pharmaceuticals | $25.16 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.12 | 2021 | |
| Legend Biotech USA INC. | $25.00 | 2025 | Carvykti |
| Novocure INC. | $24.96 | 2024 | Optune Lua (Novottf-200t) |
| Napo Pharmaceuticals INC | $24.63 | 2024 | Gelclair Concentrated Oral Gel |
| Beone Medicines USA, INC. | $24.15 | 2025 | Tevimbra |
| Eusa Pharma (US) LLC | $23.89 | 2022 | |
| Octapharma USA, INC. | $23.77 | 2023 | Panzyga |
| Adc Therapeutics America, INC. | $23.67 | 2025 | |
| Mylan Institutional INC. | $23.12 | 2023 | Hulio |
| Beigene USA, INC. | $21.46 | 2024 | Brukinsa |
| Acrotech Biopharma INC. | $21.39 | 2024 | Beleodaq |
| Genmab U.S., INC. | $20.86 | 2024 | Epkinly |
| Spectrum Pharmaceuticals INC. | $20.81 | 2025 | Rolvedon |
| Alexion Pharmaceuticals, INC. | $20.74 | 2023 | Ultomiris |
| Cumberland Pharmaceuticals, INC. | $19.33 | 2024 | Sancuso |
| Emd Serono, INC. | $19.00 | 2024 | |
| Immunogen, INC. | $17.11 | 2023 | Elahere |
| Dendreon Pharmaceuticals LLC | $16.14 | 2025 | Provenge |
Drugs and devices associated with these payments
Tecvayli $693Enhertu $621Darzalex $597Keytruda $547Reblozyl $393Kisqali $301Tukysa $297Nubeqa $285Talvey $270Rybrevant $257Erleada $233Ibrance $224Jemperli $203Zejula $203Imbruvica $200Xtandi $199Orserdu $180Xofigo $177Opdivo $161Vitrakvi $151Stivarga $151Padcev $134Lorbrena $120Lynparza $116Krazati $115Epkinly $110Zepzelca $110Pluvicto $108Poteligeo $108Venclexta $108Braftovi $104Tagrisso $96.45Vonjo $90.22Cablivi $89.79Injectafer $87.76Welireg $86.49Mektovi $84.82Pomalyst $84.00Piqray $81.71Enjaymo $80.35Monjuvi $79.76Iclusig $77.81Verzenio $69.76Jaypirca $69.76Promacta $69.64Elahere $69.40Jakafi $69.27Lenvima $69.14Kyprolis $68.20Libtayo $67.94Zoladex $64.14Rubraca $61.46Comirnaty $60.11Alymsys $58.36Onivyde $57.66Calquence $56.27Datroway $53.15Cabometyx $52.93Fotivda $51.53Besremi $49.28Rytelo $49.12Keytruda Qlex $47.25Inlyta $46.32Lupron Depot $44.35Alunbrig $44.11Elrexfio $44.01Bosulif $44.01Camcevi $42.65Somatuline Depot $41.77Itovebi $41.22Ojjaara $40.81Odomzo $39.15Udenyca $38.42Xalkori $37.65Opdualag $36.75Talzenna $36.08Polivy $31.17Zynyz $29.38Doptelet $29.30Pemazyre $27.84Lutathera $26.74Danziten $26.24Mi Cancer Seek $25.74Fruzaqla $25.55Ninlaro $25.33Carvykti $25.00Optune Lua (Novottf-200t) $24.96Gelclair Concentrated Oral Gel $24.63Cosela $24.26Cimerli $24.24Tevimbra $24.15Sarclisa $23.77Panzyga $23.77Zynlonta $23.67Hulio $23.12Vyloy $23.00Adcetris $23.00Hyqvia $22.94Paxlovid $22.77Tazverik $22.45
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Caprio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.